Cargando…

Gemcitabine in Recurrent Meningioma

Detalles Bibliográficos
Autores principales:	Khaddar, Satvik, Bhelekar, Arti, Dale, Ochin, Varghese, Litty, Patil, Vijay Maruti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Private Ltd 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205554/ https://www.ncbi.nlm.nih.gov/pubmed/34141689 http://dx.doi.org/10.1055/s-0040-1721178

Ejemplares similares

A Survey of Satisfaction with Treatment among Brain Tumor Patients
por: Singh, Gunjesh Kumar, et al.
Publicado: (2020)

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma
por: Karn, Anukul, et al.
Publicado: (2021)

Nodal Langerhans cell neoplasm: detailing the diagnostic quandaries
por: Chowdhury, Zachariah, et al.
Publicado: (2021)

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer
por: Patil, Vijay, et al.
Publicado: (2019)

Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective Review
por: Khaddar, Satvik, et al.
Publicado: (2022)

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once‐a‐week versus once‐every‐3‐weeks cisplatin
por: Menon, Nandini S., et al.
Publicado: (2022)

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma
por: Patil, Vijay M., et al.
Publicado: (2020)

Meningioma recurrence
por: Hortobágyi, Tibor, et al.
Publicado: (2016)

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo
por: Takeda, Hiroyuki, et al.
Publicado: (2017)

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation—a phase 3 study
por: Joshi, Amit, et al.
Publicado: (2021)

Recurrent Sphenocavernous Meningioma
por: Inoue, Mizuho, et al.
Publicado: (2021)

Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in a rare type of very locally advanced sinonasal carcinomas – long-term results from a tertiary care centre
por: Saha, Saswata, et al.
Publicado: (2023)

ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

ET-6 Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Antigen expression on recurrent meningioma cells
por: Vranic, Andrej
Publicado: (2010)

Recurrent intraventricular meningioma with malignant transformation
por: Singh, Jasmit, et al.
Publicado: (2017)

Psychosis secondary to recurrent spinal meningioma
por: Xiao, Min-Jia, et al.
Publicado: (2019)

Molecular Biological Determinations of Meningioma Progression and Recurrence
por: Linsler, Stefan, et al.
Publicado: (2014)

A Posterior Petrous Meningioma with Recurrent Vertigo
por: Choi, Seong Jun, et al.
Publicado: (2012)

Recurrent Spinal Meningioma: A Case Report
por: Choi, Hoi Jung, et al.
Publicado: (2012)

Management of Recurrent Meningiomas: State of the Art and Perspectives
por: Corniola, Marco Vincenzo, et al.
Publicado: (2022)

Case Report: Recurrent meningioma with multiple metastases
por: Zhou, Juyue, et al.
Publicado: (2023)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

Histological transformation in recurrent WHO grade I meningiomas
por: Corniola, Marco V., et al.
Publicado: (2020)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Factors Related to the Post-operative Recurrence of Atypical Meningiomas
por: Ye, Wu, et al.
Publicado: (2020)

Benefits of re-do surgery for recurrent intracranial meningiomas
por: Lemée, Jean-Michel, et al.
Publicado: (2020)

The coexistence of recurrent pituitary adenoma and meningioma: case report
por: Wu, Ruhong, et al.
Publicado: (2020)

Recurrent Giant Cell Tumor of Distal Radius with Pulmonary Metastasis: A Case Report
por: Pai, Satvik N., et al.
Publicado: (2021)

Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Hong, Shaodong, et al.
Publicado: (2016)

Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
por: Murata, Akihiro, et al.
Publicado: (2013)

Multifocal Meningioma Recurrence Detected on Ga68-DOTANOC Scan
por: Gupta, Nitin, et al.
Publicado: (2020)

Meta-gene markers predict meningioma recurrence with high accuracy
por: Zador, Zsolt, et al.
Publicado: (2020)

Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas
por: Oermann, Eric Karl, et al.
Publicado: (2013)

Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence
por: Fan, Song-Yuan, et al.
Publicado: (2015)

Bony Hyperostosis Recurrence after Complete Resection of Sphenoorbital Meningioma
por: Alzhrani, Gmaan, et al.
Publicado: (2017)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas
por: Fernandez, Christian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uau6b25otnaakcjdgo58cu97bg